Sky High Medex serves as a specialized B2B gateway for Apixaban 5mg Tablets, providing essential cardiovascular and hematological solutions to medical wholesalers, cardiology specialists, and hospital procurement groups across Australia, New Zealand, and the Pacific Islands. Apixaban 5mg is a Direct Oral Anticoagulant (DOAC) and a selective factor Xa inhibitor, widely utilized in the Oceania clinical landscape. It is a cornerstone therapy for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). Furthermore, it is a clinical standard for the treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), as well as the prevention of recurrent DVT and PE. By targeting factor Xa in the blood's natural clotting process, Apixaban provides effective anticoagulation with a predictable response, often eliminating the need for routine blood monitoring required by older therapies. Operational Highlights for the Australasian Market: Wholesale Supply Chain: We manage high-volume procurement directly from our Nagpur HQ, ensuring Oceania-based buyers have consistent access to fresh-batch, high-stability inventory from leading global manufacturers. Secured Postal Transit: All consignments are dispatched via fully tracked international postal services, providing end-to-end visibility for deliveries into major hubs like Sydney, Auckland, Melbourne, and Brisbane. B2B Privacy & Protection: We prioritize professional confidentiality with discreet, industrial-grade packaging designed to maintain product stability and ensure smooth customs processing within the region. Quality Compliance: Each shipment is accompanied by comprehensive manufacturer batch records and Certificates of Analysis (COA) to meet local pharmaceutical standards and inventory verification requirements. Contact our dedicated export desk for current batch availability and tiered bulk pricing. WhatsApp: +91 9270847472 Email: skyhighmedex@gmail.com Location: Nagpur, India (Global Distribution HQ)